Skip to main content
Premium Trial:

Request an Annual Quote

FDA Grants Emergency Use Authorization for Northeastern University SARS-CoV-2 Test

NEW YORK — The US Food and Drug Administration on Wednesday granted Emergency Use Authorization for an RT-PCR-based SARS-CoV-2 test developed by Northeastern University's Life Sciences Testing Center.

The Life Sciences Testing Center COVID-19 Test is designed to detect the SARS-CoV-2 N, ORF1ab, and S genes in anterior nasal specimens self-collected using the Life Sciences Testing Center COVID-19 Home Collection Kit.

The test uses the authorized Thermo Fisher Scientific TaqPath COVID-19 Combo Kit and runs on Thermo Fisher's Applied Biosystems 7500 Fast Dx system. The test may only be used by the Life Sciences Testing Center, according to the FDA.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.